{"id": "1354934113036349448", "creation": 1611876440.0, "user_id": "3189956085", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "Novavax #vaccine #covid19\nResults from phase 3 trial: 89.3% efficacy. \n\nGood ... but with some concern because data from the South African arm of the trial (where B.1.351 variant is common) show 50% efficacy rate.\n\nhttps://t.co/5ouzPpkVMR", "first_save": 1634559108.199414, "hashtags": ["#VACCINE", "#COVID19"]}